Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydromethylthionine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA known ✓ | P10253 | 3/20 | 0.42 |
| ▸ | BCHE known ✓ | P06276 | 1/20 | 0.40 |
| ▸ | MAOA known ✓ | P21397 | 1/20 | 0.40 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.40 |
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.40 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.40 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.40 |
| ▸ | PTGS2 known ✓ | P35354 | 1/20 | 0.40 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.40 |
| ▸ | HDAC3 known ✓ | O15379 | 1/20 | 0.36 |
| ▸ | HDAC4 known ✓ | P56524 | 1/20 | 0.36 |
| ▸ | HDAC2 known ✓ | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC8 known ✓ | Q9BY41 | 1/20 | 0.36 |
| ▸ | SNCA | P37840 | 8/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | NOX1 | Q9Y5S8 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydromethylthionine SCHEMBL29625238 | 1.00 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL31159644 | 1.00 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL31481566 | 0.98 | SNCA (0.47) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL109756 | 0.98 | SNCA (0.50) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL29356148 | 0.98 | SNCA (0.50) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL12592446 | 0.98 | SNCA (0.50) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL23683393 | 0.96 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL12470963 | 0.96 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL25194477 | 0.96 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 | |
| Hydromethylthionine SCHEMBL31159649 | 0.96 | SNCA (0.48) | SNCAMAPTNOX1GAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9320436-B2 | Method and device for detecting deposits in the eye | CARL ZEISS MEDITEC AG (DE) | 2016-04-26 | — | — | US | claimed |
| US-20150119238-A1 | METHOD AND DYE MIXTURES FOR MARKING SHAPE MEMORY POLYMERS, AND SHAPE MEMORY POLYMER ARTICLES WITH SWITCHABLE READABILITY | BAM BUNDESANSTALT FUER MATERIALFORSCHUNG UND - PRUEFUNG (DE) | 2015-04-30 | — | — | US | claimed |
| EP-2771392-A2 | METHOD AND DYE MIXTURES FOR MARKING SHAPE MEMORY POLYMERS, AND SHAPE MEMORY POLYMER ARTICLES WITH SWITCHABLE READABILITY | BAM Bundesanstalt für Materialforschung und -prüfung (DE) | 2014-09-03 | — | — | EP | claimed |
| WO-2013060831-A2 | METHOD AND DYE MIXTURES FOR MARKING SHAPE MEMORY POLYMERS, AND SHAPE MEMORY POLYMER ARTICLES WITH SWITCHABLE READABILITY | BAM Bundesanstalt für Materialforschung und -prüfung (DE) | 2013-05-02 | — | — | WO | claimed |
| US-20120229766-A1 | METHOD AND DEVICE FOR DETECTING DEPOSITS IN THE EYE | CARL ZEISS MEDITEC AG (DE) | 2012-09-13 | — | — | US | claimed |
| WO-2011038892-A1 | METHOD AND DEVICE FOR DETECTING DEPOSITS IN THE EYE | CARL ZEISS MEDITEC AG (DE) | 2011-04-07 | — | — | WO | claimed |
| EP-0674021-B1 | Process for inhibiting metal corrosion in aquous systems | SCHILLING CHEMIE GMBH U PRODUK (DE) | 2000-12-06 | — | — | EP | claimed |
| EP-0674021-A1 | Process for inhibiting metal corrosion in aquous systems | Schilling Chemie GmbH u. Produktion KG (DE) | 1995-09-27 | — | — | EP | claimed |
| EP-4613784-A1 | ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME | Mitsubishi Chemical Corporation (JP) | 2025-09-10 | — | — | EP | disclosed |
| EP-4613785-A1 | ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND (METH)ACRYLIC POLYMER AND METHOD FOR PRODUCING SAME | Mitsubishi Chemical Corporation (JP) | 2025-09-10 | — | — | EP | disclosed |
| EP-4610284-A1 | MONOMER COMPOSITION, METHACRYLIC RESIN COMPOSITION AND PRODUCTION METHOD THEREFOR, AND MOLDED RESIN OBJECT | Mitsubishi Chemical Corporation (JP) | 2025-09-03 | — | — | EP | disclosed |
| US-20250250370-A1 | METHACRYLATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING METHACRYLIC ESTER, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING METHACRYLIC ACID POLYMER | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-08-07 | — | — | US | disclosed |
| US-20250250221-A1 | ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND (METH)ACRYLIC POLYMER AND METHOD FOR PRODUCING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-08-07 | — | — | US | disclosed |
| US-20250250223-A1 | ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-08-07 | — | — | US | disclosed |
| US-5721295-A | CONSISTS OF WATER SOLUBLE OR WATER SWELLABLE POLYSACHHARIDE OR DERIVATIVE, A SYNTHETIC POLYMER OR COPOLYMER, AN ORGANIC MATRIX, CROSSLINKER, REACTIVE ADDITIVE AND ANTI-BLOCKING AGENT | CHEMISCHE FABRIK STOCKHAUSEN GMBH (DE) | 1998-02-24 | — | — | US | disclosed |
| EP-0700414-B1 | POLYMER COMPOSITION, ABSORBENT MATERIAL COMPOSITION, THEIR PRODUCTION AND USE | STOCKHAUSEN CHEM FAB GMBH (DE) | 1997-08-06 | — | — | EP | disclosed |
| EP-0674021-A1 | Process for inhibiting metal corrosion in aquous systems | Schilling Chemie GmbH u. Produktion KG (DE) | 1995-09-27 | — | — | EP | disclosed |
| EP-0674021-A1 | Process for inhibiting metal corrosion in aquous systems | Schilling Chemie GmbH u. Produktion KG (DE) | 1995-09-27 | — | — | EP | disclosed |
| US-4466978-A | USING ASCORBIC ACID, GLUTATHIONE AND METHYLENE BLUE | Naylor, Graham John (GB) | 1984-08-21 | — | — | US | disclosed |
| US-4414212-A | Method of treatment of pre-menstrual syndrome | Naylor, Graham J. (GB) | 1983-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250250221-A1 | ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND (METH)ACRYLIC POLYMER AND METHOD FOR PRODUCING SAME | ADCY6, ADCY5, AMD1 | GAA 2219/4885BCHE 1060/4885MAOA 615/4885 |
| US-20250250370-A1 | METHACRYLATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING METHACRYLIC ESTER, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING METHACRYLIC ACID POLYMER | MMAB, MAT2B, MEP1B | GAA 2797/4885BCHE 2486/4885MAOA 23/4885 |
| US-20250250223-A1 | ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME | MMAB, ADCY8, MAT1A | GAA 1744/4885BCHE 452/4885MAOA 1025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.